Lurie Cancer Center Members
Membership in the Lurie Cancer Center is based on the investigator's cancer research focus and scholarly activity. A program assignment recommendation is made by the Executive Committee with final approval issued by the cancer center's director. Full members are assigned to a program in the Basic Science Research Division, the Clinical Science Research Division or the Cancer Prevention & Control Research Division. All members are welcome and encouraged to participate in any educational activities initiated by the Lurie Cancer Center.
Yi, Yang
Assistant Professor
Bio
The goal of Dr. Yi's research centers on uncovering the previously unrecognized functions of epigenetic modification during normal and pathological bioprocesses, and decoding the potential crosst... [more]
Yue, Feng
Professor
Bio
The long-term goal of Dr. Yue's group is to use a combination of high throughput genomics, computational modeling, and functional assays to study how genetic variants contribute to the pathogenes... [more]
Zhang, Bin
Professor
Bio
Cancer immunology and immunotherapy.The Zhang laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic strateg... [more]
Zhang, Christine
Assistant Professor
Bio
My lab is interested in understanding how genetic and epigenetic factors cooperates to initiate leukemogenesis and other hematological malignancies.
Zhang, Hao
Professor
Bio
The Functional Optical Imaging Lab (FOIL) at Northwestern University is dedicated to develop novel optical, ultrasonic, and electrical imaging techniques for biomedical research and clinical... [more]
Zhang, Peng
Assistant Professor
Bio
The goal of Dr. Zhang's research is to establish the feasibility of precisely targeting and modulating brain tumors and the surrounding immune microenvironment as new translatable therapeutic approach... [more]
Zhang, Wei
Professor
Bio
Dr. Zhang's major research interests include the genetics and epigenetics of complex traits, such as risks for common diseases, drug response, and gene expression. Dr. Zhang is also developing novel e... [more]
Zhang, Xiaoyu
Assistant Professor
Bio
Our research group seeks to develop small molecule therapeutic modalities, including protein degraders and stabilizers, and cancer neoantigen inducers and modifiers, that modulate cancer priority targ... [more]
Zhang, Zheng Jenny
Research Professor
Bio
Cell/organ transplantation are preferred treatment for patients with end stage organ failure caused by chronic diseases as well as cancer. However, people who have had solid organ transplants ... [more]
Zhao, Zibo
Assistant Professor
Bio
Genome instability and mutation is one of the enabling characteristics of cancer. Epigenetic factor mutations, including MLL3/4-UTX-COMPASS are prevalent in human cancers and developmental diseases. D... [more]